Anti Glaucoma Eyedrops Market Report 2024 (Global Edition)

Global Anti Glaucoma Eyedrops Market Report 2024 Market Size Split by Product type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others), by Disease Condition (Open –ang...

Anti Glaucoma Eyedrops Market Report Description

We have various report editions of Anti Glaucoma Eyedrops Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Anti Glaucoma Eyedrops Market Insights Video

Competitive Landscape of Anti Glaucoma Eyedrops

Another factor that is anticipated to support expansion in the market under study is the growing emphasis that businesses place on R&D initiatives and the rising adoption of different business strategies like acquisitions, mergers, collaborations, and partnerships.

• February 2020: Richard Ashworth was named president of Walgreens, however he left the company after only a year. He presided over operations for Walgreens prior to being appointed.
• June 2020: To make total health insurance more affordable and available to Michigan enterprises and clients, Cigna and Priority Health entered into a strategic partnership.

(Source:www.priorityhealth.com/about-us/for-the-media/news-releases/priority-health-and-cigna-form-strategic-alliance#:~:text=%E2%80%93%20June%2022%2C%202020)%20Priority,employers%2C%20their%20employees%20and%20families.)

Top Companies Market Share in Anti Glaucoma Eyedrops Industry: (In no particular order of Rank)

• Walgreens
• Meda Pharmaceuticals Inc.
• Bausch and Lomb Inc.
• Cigna
• Visine
• Clear Eyes
• Alcon
• Viva Opti-Free
• Bausch and Lomb
• Novartis AG
• Systane
• Rite Aid
• Allergan
• Inc.
• Staples
• Similasan Corporation
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, North America Automotive Steering System Market share was 35% of total market

Due to a number of factors, North America controlled the market in 2022 and contributed more than 35% of the global revenue, according to Cognitive Market Research. The market for anti-glaucoma eye drops is dominated by North America. Governments of affluent nations in this region are attempting to initiate programmes to raise awareness of glaucoma and comparable other eye problems because the incidence of glaucoma climbs with age and this region has the world's largest elderly population. For instance, to avoid eye diseases like glaucoma and to enhance overall eye health, the center for the Prevention and Control of Diseases (CDC) in the United States created the Vision Health project. A medicine's ability to lower intraocular pressure (IOP) and its benefit-to-hazard ratio should be equivalent to those of the benchmark drug in order for the US Food and medicine Administration (USFDA) to approve it. For instance, the U.S. FDA authorized Rhopressa (netarsudil) Ophthalmic Solution by Aerie Pharmaceuticals Inc. based on its capacity to reduce OP in comparison to market-benchmarked glaucoma medications.

With a CAGR of 9.6%, Asia Pacific will likely experience the fastest growth. Large patient pools, high illness prevalence, and the creation of regional businesses are all thought to have contributed to the expansion of the Asia-Pacific area. Although there are more patients in the Asia-Pacific region than anywhere else, there is also a lower treatment rate there. The expansion of the region is also anticipated to be boosted by a number of strategic actions performed by market participants. For instance, Otsuka Pharmaceutical Co., Ltd. and Senju Pharmaceutical Co., Ltd. announced in June 2020 the release of AILAMIDE, a combination ophthalmic solution for treatment of ocular hypertension and glaucoma.

The current report Scope analyzes Anti Glaucoma Eyedrops Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

Anti Glaucoma Eyedrops Market Analysis

Product Type Segment Analysis

As more commonly prostaglandin analogs are used to treat the illness, segmental demand for the medication class will rise because to their several advantages, including efficacy with a single everyday dose. Due to the rising demand for prostaglandin drugs used in combination therapy, the category is also predicted to expand significantly. Because they successfully lower intraocular pressure and have fewer side effects than other treatments, the prostaglandin analog business has continued to have the largest market share for the medications. Latanoprost, bimatoprost, travoprost, and other compounds are covered in separate subsections within the prostaglandins section.. 

Because they have fewer side effects than other types of medications, alpha agonists are also anticipated to experience the quickest growth in the antiglaucoma eye drop market throughout the projected period. Adrenergic receptors are mostly found in the smooth muscles of blood arteries and the myocardial tissue, which is the heart muscle. The blood vessels contract when these receptors are turned on.

• Alpha Agonist
• Beta Blockers
• Prostaglandin Analogs
• Combined Medication
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Anti Glaucoma Eyedrops Industry. Request a Free Sample PDF!

Disease Condition Segment Analysis

The open angle led the market in the disease-type sector, and it is believed that this trend would persist for the entire anticipated time frame. This is unique from other forms of glaucoma because of the high prevalence of the illness. Most cases of glaucoma are caused by primary open-angle glaucoma (OAG). When the eye is functioning normally, fluid departs the anterior chamber through the space between the cornea and iris and vanishes from sight. When OAG is present, the fluid slowly leaks out and builds up, raising the pressure inside the eye and perhaps causing a steady deterioration of vision. Due to the aging population's rise and the prevalence of chronic eye disorders, there is an increasing demand for open-angle glaucoma treatment and care. Even without symptoms, open-angle glaucoma can develop.

Acute angle-closure glaucoma (ACG), also known as angle-closure or narrow-angle glaucoma, is less prevalent and occurs when the iris blocks the angle. It is the disease with the fastest growing incidence of angle-closure. ACG can quickly cause vision loss if ignored. Your iris and cornea's "angle" "closes" as they come closer to one another.

• Open –angle Glaucoma
• Angle-closure Glaucoma
• Normal-tension Glaucoma
• Congenitial Glaucoma
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Sneha Mali

Research Analyst at Cognitive Market Research

LinkedIn

Profile

I am a research analyst working in various domains including the Consumer Goods domain, and my primary responsibility is to conduct thorough research on various subjects and provide valuable insights to support client requirements. I have knowledge of research methodologies, and data mining which enables me to analyze large data sets, draw meaningful conclusions, and communicate them effectively. I stay up-to-date with the latest research trends, methodologies, and technologies to ensure that my research is accurate, relevant, and impactful.

Author's Conclusion